达福普汀 (Synercid)

概览

Dalfopristin is an antibiotic used with quinupristin to treat severe or life-threatening infections of vancomycin-resistant Enterococcus faecium (VREF), and skin infections caused by methicillin susceptible staphylococcus aureus or streptococcus pyogenes.

作用机制

The site of action of dalfopristin is the bacterial ribosome. Dalfopristin has been shown to inhibit the early phase of protein synthesis.

适应症

For the treatment of bacterial infections (usually in combination with quinupristin).

• Bacterial Infections
• Methicillin Resistant Staphylococcus Aureus Infection (MRSA)
• Complicated Skin and subcutaneous tissue bacterial infection